Tango Therapeutics Inc (TNGX)
7.47
-0.20
(-2.61%)
USD |
NASDAQ |
May 21, 16:00
7.46
-0.01
(-0.13%)
After-Hours: 20:00
Tango Therapeutics Total Liabilities (Quarterly): 141.77M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 141.77M |
| December 31, 2023 | 149.46M |
| September 30, 2023 | 151.59M |
| June 30, 2023 | 166.38M |
| March 31, 2023 | 176.51M |
| December 31, 2022 | 186.99M |
| Date | Value |
|---|---|
| September 30, 2022 | 191.08M |
| June 30, 2022 | 149.70M |
| March 31, 2022 | 151.17M |
| December 31, 2021 | 155.41M |
| September 30, 2021 | 164.72M |
| December 31, 2020 | 168.65M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
141.77M
Minimum
Mar 2024
191.08M
Maximum
Sep 2022
162.79M
Average
160.07M
Median
Total Liabilities (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 165.82M |
| 2seventy bio Inc | 303.61M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 406.22M |
| Shareholders Equity (Quarterly) | 264.45M |
| Current Ratio | 8.227 |